Zionexa
About:
Zionexa is an international and innovative company developing and commercializing in-vivo biomarkers.
Website: https://www.zionexa.com/
Twitter/X: zionexaofficial
Top Investors: IXO Private Equity, Sofimac Innovation
Description:
Zionexa is an international and innovative company developing and commercializing in-vivo biomarkers for guiding targeted therapies in oncology, to improve patients’ pathway and provide them a better quality of life.
Total Funding Amount:
$5M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Fishers, Indiana, United States
Founded Date:
2018-01-01
Founders:
Number of Employees:
11-50
Last Funding Date:
2019-04-11
IPO Status:
Private
Industries:
© 2025 bioDAO.ai